Penanganan dan Pembalikan Antikoagulan

Reversal of antithrombotic agents. (terbuka di window baru)

Bauer KA.

Sumber‎: Am J Hematol 2012;87 Suppl 1:S119-26.

Index‎: PubMed 22460529

DOI‎: 10.1002/ajh.23165

https://www.ncbi.nlm.nih.gov/pubmed/22460529 (terbuka di window baru)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (terbuka di window baru)

Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M

Sumber‎: J Thromb Haemost 2015;13(10):1790-8.

Index‎: PubMed 26270886

DOI‎: 10.1111/jth.13117

https://www.ncbi.nlm.nih.gov/pubmed/26270886 (terbuka di window baru)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (terbuka di window baru)

Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, Curnutte JT, Lawrence JH, Yue P, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Demchuk AM, Pallin DJ, Concha M, Goodman S, Leeds J, Souza S, Siegal DM, Zotova E, Meeks B, Ahmad S, Nakamya J, Milling TJ Jr; ANNEXA-4 Investigators

Sumber‎: N Engl J Med 2019;380(14):1326-35.

Index‎: PubMed 30730782

DOI‎: 10.1056/NEJMoa1814051

https://www.ncbi.nlm.nih.gov/pubmed/30730782 (terbuka di window baru)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (terbuka di window baru)

Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators

Sumber‎: N Engl J Med 2016;375(12):1131-41.

Index‎: PubMed 27573206

DOI‎: 10.1056/NEJMoa1607887

https://www.ncbi.nlm.nih.gov/pubmed/27573206 (terbuka di window baru)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (terbuka di window baru)

Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M

Sumber‎: Circulation 2011;124(14):1573-9.

Index‎: PubMed 21900088

DOI‎: 10.1161/CIRCULATIONAHA.111.029017

https://www.ncbi.nlm.nih.gov/pubmed/21900088 (terbuka di window baru)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (terbuka di window baru)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Sumber‎: Lancet 2015;385(9982):2077-87.

Index‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (terbuka di window baru)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (terbuka di window baru)

Gordon JL, Fabian TC, Lee MD, Dugdale M

Sumber‎: J Trauma Acute Care Surg 2013;75(3):475-86.

Index‎: PubMed 24089118

DOI‎: 10.1097/TA.0b013e3182a07391

https://www.ncbi.nlm.nih.gov/pubmed/24089118 (terbuka di window baru)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (terbuka di window baru)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Sumber‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Index‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (terbuka di window baru)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (terbuka di window baru)

Levi M, Eerenberg E, Kamphuisen PW.

Sumber‎: J Thromb Haemost 2011;9(9):1705-12.

Index‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (terbuka di window baru)

Emergency reversal of warfarin anticoagulation. (terbuka di window baru)

Lin Y, Callum J.

Sumber‎: CMAJ 2010;182(18):2004.

Index‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (terbuka di window baru)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (terbuka di window baru)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Sumber‎: Thromb Haemost 2012;108(2):217-24.

Index‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (terbuka di window baru)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (terbuka di window baru)

Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H; Beriplex P/N Anticoagulation Reversal Study Group.

Sumber‎: J Thromb Haemost 2008;6(4):622-31.

Index‎: PubMed 18208533

DOI‎: 10.1111/j.1538-7836.2008.02904.x

https://www.ncbi.nlm.nih.gov/pubmed/18208533 (terbuka di window baru)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (terbuka di window baru)

Piran S, Khatib R, Schulman S, Majeed A, Holbrook A, Witt DM, Wiercioch W, Schünemann HJ, Nieuwlaat R

Sumber‎: Blood Adv 2019;3(2):158-67.

Index‎: PubMed 30658963

DOI‎: 10.1182/bloodadvances.2018024133

https://www.ncbi.nlm.nih.gov/pubmed/30658963 (terbuka di window baru)

Idarucizumab for dabigatran reversal. (terbuka di window baru)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Sumber‎: N Engl J Med 2015;373(6):511-20.

Index‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (terbuka di window baru)

Idarucizumab for dabigatran reversal - full cohort analysis. (terbuka di window baru)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Sumber‎: N Engl J Med 2017;377(5):431-41.

Index‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (terbuka di window baru)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (terbuka di window baru)

Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B

Sumber‎: Blood 2003;102(13):4594-9.

Index‎: PubMed 12920042

DOI‎: 10.1182/blood-2002-11-3566

https://www.ncbi.nlm.nih.gov/pubmed/12920042 (terbuka di window baru)

Role of agents for reversing the effects of target-specific oral anticoagulants. (terbuka di window baru)

Riley TR, Gauthier-Lewis ML, Sanchez CK, Douglas JS

Sumber‎: Am J Health Syst Pharm 2017;74(2):54-61.

Index‎: PubMed 27895055

DOI‎: 10.2146/ajhp150810

https://www.ncbi.nlm.nih.gov/pubmed/27895055 (terbuka di window baru)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (terbuka di window baru)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Sumber‎: Anesth Analg 2011;113(4):703-10.

Index‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (terbuka di window baru)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (terbuka di window baru)

Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, Florido R, Hucker W, Mehran R, Messé SR, Pollack CV Jr, Rodriguez F, Sarode R, Siegal D, Wiggins BS

Sumber‎: J Am Coll Cardiol 2017;70(24):3042-67.

Index‎: PubMed 29203195

DOI‎: 10.1016/j.jacc.2017.09.1085

https://www.ncbi.nlm.nih.gov/pubmed/29203195 (terbuka di window baru)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (terbuka di window baru)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Sumber‎: World Neurosurg 2014;81(1):110-5.

Index‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (terbuka di window baru)

Reversal of warfarin-induced hemorrhage in the emergency department. (terbuka di window baru)

Zareh M, Davis A, Henderson S.

Sumber‎: West J Emerg Med 2011;12(4):386-92.

Index‎: PubMed 22224125

DOI‎: 10.5811/westjem.2011.3.2051

https://www.ncbi.nlm.nih.gov/pubmed/22224125 (terbuka di window baru)

PERAWATAN INTENSIF DAN KRITIS

Penanganan dan Pembalikan Antikoagulan

Indonesia

Penanganan dan Pembalikan Antikoagulan

https://assetsnffrgf-a.akamaihd.net/assets/ct/46e9307b0a/images/syn_placeholder_sqr.png

Reversal of antithrombotic agents. (terbuka di window baru)

Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. (terbuka di window baru)

Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. (terbuka di window baru)

Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. (terbuka di window baru)

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. (terbuka di window baru)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (terbuka di window baru)

Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. (terbuka di window baru)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (terbuka di window baru)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (terbuka di window baru)

Emergency reversal of warfarin anticoagulation. (terbuka di window baru)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (terbuka di window baru)

Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. (terbuka di window baru)

Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. (terbuka di window baru)

Idarucizumab for dabigatran reversal. (terbuka di window baru)

Idarucizumab for dabigatran reversal - full cohort analysis. (terbuka di window baru)

Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. (terbuka di window baru)

Role of agents for reversing the effects of target-specific oral anticoagulants. (terbuka di window baru)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (terbuka di window baru)

2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. (terbuka di window baru)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (terbuka di window baru)

Reversal of warfarin-induced hemorrhage in the emergency department. (terbuka di window baru)

Hubungi Perwakilan Setempat dari Panitia Penghubung Rumah Sakit

Paket Informasi Medis

Video

Penanganan dan Pembalikan Antikoagulan

Pilih Bahasa Anda

Bagikan